Scarica l'app Stockscreener
1.33
8.13%
0.10
Pre-mercato:
1.26
-0.07
-5.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial - Stocktwits
ApolloBio reports positive phase 3 results for VGX-3100 in China - Investing.com UK
Positive Phase 3 Results for Inovio (INO) Partnered VGX-3100 in China - GuruFocus
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio (NASDAQ: INO) director awarded RSUs and 41,800 options - Stock Titan
[Form 4] INOVIO PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Inovio (NASDAQ: INO) grants RSUs and stock options to director Ann Calby Miller - Stock Titan
Equity grants to Inovio (NASDAQ: INO) director David Weiner disclosed - Stock Titan
Inovio (NASDAQ: INO) director receives RSUs and stock options grant - Stock Titan
Inovio (NASDAQ: INO) director granted 34,200 RSUs and 41,800 options - Stock Titan
INOVIO (INO) Chief Scientific Officer reports RSU vesting, tax withholding and new stock option awards - Stock Titan
Inovio (INO) CMO granted RSUs and 46,876 stock options at $1.73 - Stock Titan
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China - PR Newswire
Inovio (INO) CFO granted stock options, RSUs and reports RSU vesting - Stock Titan
Inovio (NASDAQ: INO) CEO receives new RSUs and options as shares withheld for taxes - Stock Titan
Inovio Shareholders Endorse Governance Changes and Leadership - TipRanks
Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Inovio (NASDAQ: INO) overhauls board roles and wins approval on all 2026 shareholder proposals - Stock Titan
Inovio Pharmaceuticals Q3 2025 Earnings Preview - MSN
Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who L - GuruFocus
$Moderna (MRNA.US)$ $Inovio Pharmaceuticals (INO.US)$ $3M (MMM.US)$ - Moomoo
Earnings call transcript: Inovio beats Q1 2026 EPS forecast but stock slips - Investing.com UK
Earnings call transcript: Inovio beats Q1 2026 EPS forecast but stock slips By Investing.com - Investing.com South Africa
Inovio Stock Price Today | NASDAQ: INO Live - Investing.com
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio (NASDAQ: INO) CEO nets shares from RSU vesting and tax withholding - Stock Titan
Inovio Pharmaceuticals (INO) CFO exercises 4,771 RSUs and has 2,571 shares withheld for taxes - Stock Titan
INOVIO (NASDAQ: INO) CSO settles RSUs, shares withheld for tax - Stock Titan
INOVIO (NASDAQ: INO) CMO vests RSUs and withholds shares for taxes - Stock Titan
Inovio Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:INO) 2026-05-16 - Seeking Alpha
INO Should I Buy - Intellectia AI
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2026 Earnings Call Transcript - Insider Monkey
Highbridge reports 6.19M warrant‑issued shares in Inovio (INO) - Stock Titan
Investigation Alert: Investors who hold shares of Inovio - openPR.com
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
Inovio Pharmaceuticals stock (US45773H2013): Q1 2026 results and INO-3107 FDA review - AD HOC NEWS
Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO) - Seeking Alpha
Q1 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Inovio Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
INOVIO Reports First Quarter 2026 Financial Results and Recent B - GuruFocus
Inovio Pharmaceuticals Inc (INO) Q1 2026 Earnings Call Highlights: Progress and Challenges in Advancing INO-3107 - GuruFocus
Inovio outlines cash runway into Q1 2027 as INO-3107 targets October 30, 2026 PDUFA date - MSN
Inovio and Fossil Q1 results highlight strategic progress - MSN
Salt Lake City Topic INOVIO PHARMACEUTICALS, INC. | News, Weather, Sports, Breaking News - KMYU
Earnings call transcript: Inovio’s Q1 2026 highlights clinical progress, stock rises 2.84% - Investing.com UK
Inovio Pharmaceuticals (INO) Q1 2026 Earnings Report Highlights Progress and Cash Position - GuruFocus
Is Inovio Pharmaceuticals (INO) Still 545.2% Overvalued After Q1 - GuruFocus
Inovio (INO) Q1 2026 Earnings Call Transcript - AOL.com
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call - Benzinga
Inovio Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Inovio’s Q1 2026 highlights clinical progress, stock rises 2.84% By Investing.com - Investing.com South Africa
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INOVIO Pharmaceuticals posts first quarter 2026 results and reviews operations - Traders Union
Inovio Pharmaceuticals posts flat Q1 net loss - TradingView
Inovio: Q1 Earnings Snapshot - Barchart.com
INOVIO (NASDAQ: INO) details Q1 loss and INO-3107 accelerated FDA review - Stock Titan
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights - The Winchester Star
4.72%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):